Kreisler A - Search Results

1

Centrosomal cohesion deficits as cellular biomarker in lymphoblastoid cell lines from LRRK2 Parkinson's disease patients.

Fernández B, Lara Ordóñez AJ, Fdez E, Mutez E, Comptdaer T, Leghay C, Kreisler A, Simonin C, Vandewynckel L, Defebvre L, Destée A, Bleuse S, Taymans JM, Chartier-Harlin MC, Hilfiker S. Fernández B, et al. Among authors: kreisler a. Biochem J. 2019 Oct 15;476(19):2797-2813. doi: 10.1042/BCJ20190315. Biochem J. 2019. PMID: 31527116 Free PMC article.

2

Corticobasal degeneration and Parkinson's disease assessed by HmPaO SPECT: the utility of factorial discriminant analysis.

Kreisler A, Defebvre L, Lecouffe P, Duhamel A, Charpentier P, Steinling M, Destée A. Kreisler A, et al. Mov Disord. 2005 Nov;20(11):1431-8. doi: 10.1002/mds.20611. Mov Disord. 2005. PMID: 16007659

3

[Can meningoencephalitis be caused by Chlamydiae pneumoniae?].

Boschin-Crinquette C, Kreisler A, Legout L, Charpentier P, Destée A, Defebvre L. Boschin-Crinquette C, et al. Among authors: kreisler a. Rev Neurol (Paris). 2005 Oct;161(10):979-83. doi: 10.1016/s0035-3787(05)85164-1. Rev Neurol (Paris). 2005. PMID: 16365630 Review. French.

4

Lipid-lowering drugs in the MPTP mouse model of Parkinson's disease: fenofibrate has a neuroprotective effect, whereas bezafibrate and HMG-CoA reductase inhibitors do not.

Kreisler A, Gelé P, Wiart JF, Lhermitte M, Destée A, Bordet R. Kreisler A, et al. Brain Res. 2007 Mar 2;1135(1):77-84. doi: 10.1016/j.brainres.2006.12.011. Epub 2007 Jan 2. Brain Res. 2007. PMID: 17196944

5

Seizure after use of almotriptan.

Mazzoleni R, Kreisler A, Lucas C, Kwiatkowski A, Gautier S, Destee A, Defebvre L. Mazzoleni R, et al. Among authors: kreisler a. Clin Neurol Neurosurg. 2008 Sep;110(8):850-1. doi: 10.1016/j.clineuro.2008.05.014. Epub 2008 Jul 3. Clin Neurol Neurosurg. 2008. PMID: 18599194

6

Myoclonus of peripheral origin: two case reports.

Tyvaert L, Krystkowiak P, Cassim F, Houdayer E, Kreisler A, Destée A, Defebvre L. Tyvaert L, et al. Among authors: kreisler a. Mov Disord. 2009 Jan 30;24(2):274-7. doi: 10.1002/mds.21998. Mov Disord. 2009. PMID: 19086086

7

[Classification of parkinsonian syndromes via factorial discriminant analysis of brain SPECT data].

Kreisler A, Defebvre L, Duhamel A, Lecouffe P, Dujardin K, Steinling M, Pasquier F, Destée A. Kreisler A, et al. Rev Neurol (Paris). 2009 May;165(5):440-8. doi: 10.1016/j.neurol.2008.11.014. Epub 2009 Jan 15. Rev Neurol (Paris). 2009. PMID: 19150099 French.

8

Lipid-lowering drugs are associated with delayed onset and slower course of Parkinson's disease.

Mutez E, Duhamel A, Defebvre L, Bordet R, Destée A, Kreisler A. Mutez E, et al. Among authors: kreisler a. Pharmacol Res. 2009 Jul;60(1):41-5. doi: 10.1016/j.phrs.2009.03.010. Epub 2009 Mar 20. Pharmacol Res. 2009. PMID: 19427584

9

Reduced levodopa-induced complications after 5 years of subthalamic stimulation in Parkinson's disease: a second honeymoon.

Simonin C, Tir M, Devos D, Kreisler A, Dujardin K, Salleron J, Delval A, Blond S, Defebvre L, Destée A, Krystkowiak P. Simonin C, et al. Among authors: kreisler a. J Neurol. 2009 Oct;256(10):1736-41. doi: 10.1007/s00415-009-5195-2. Epub 2009 Jun 18. J Neurol. 2009. PMID: 19536584

10

[Parkinson disease: genetics and neuronal death].

Destée A, Mutez E, Kreisler A, Vanbesien-Maillot C, Chartier-Harlin MC. Destée A, et al. Among authors: kreisler a. Rev Neurol (Paris). 2009 Apr;165 Spec No 2:F80-5. Rev Neurol (Paris). 2009. PMID: 19593875 Review. French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

83 results

Search Page